• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

Ethyl 4-(4-Fluorophenyl)-4-Oxobutanoate: A Comprehensive Overview

Ethyl 4-(4-fluorophenyl)-4-oxobutanoate, with the CAS number 41310-80-9, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of esters, specifically a substituted butyrate derivative. Its structure consists of a four-carbon chain (butanoate) with a fluorophenyl group attached at the fourth position, along with a ketone group at the same position. This unique combination of functional groups makes it a versatile molecule with potential applications in drug design and synthesis.

The fluorophenyl group in ethyl 4-(4-fluorophenyl)-4-oxobutanoate plays a crucial role in its chemical properties. Fluorine, being an electronegative atom, introduces electron-withdrawing effects, which can influence the reactivity and stability of the molecule. This property is particularly useful in medicinal chemistry, where such groups are often employed to modulate the pharmacokinetic profiles of drugs. Recent studies have highlighted the importance of fluorinated aromatic compounds in enhancing bioavailability and reducing toxicity, making ethyl 4-(4-fluorophenyl)-4-oxobutanoate a promising candidate for further exploration.

One of the most notable applications of ethyl 4-(4-fluorophenyl)-4-oxobutanoate is its role as an intermediate in the synthesis of more complex molecules. Its ability to undergo various organic reactions, such as nucleophilic acyl substitution and condensation reactions, makes it a valuable building block in organic synthesis. For instance, it can be used to prepare β-keto esters, which are essential precursors for the synthesis of antibiotics, antiviral agents, and other therapeutic compounds.

Recent advancements in synthetic methodology have further expanded the utility of ethyl 4-(4-fluorophenyl)-4-oxobutanoate. Researchers have demonstrated its effectiveness in asymmetric synthesis, where it serves as a chiral auxiliary to induce stereocontrol in complex molecules. This capability is particularly relevant in the development of enantiomerically pure drugs, which are increasingly demanded by the pharmaceutical industry due to their superior efficacy and reduced side effects.

In addition to its synthetic applications, ethyl 4-(4-fluorophenyl)-4-oxobutanoate has shown potential as a bioactive compound itself. Studies have indicated that it exhibits moderate inhibitory activity against certain enzymes involved in inflammatory pathways, suggesting its potential as an anti-inflammatory agent. Furthermore, its ability to modulate cellular signaling pathways makes it a candidate for investigating its role in cancer biology and neurodegenerative diseases.

The synthesis of ethyl 4-(4-fluorophenyl)-4-oxobutanoate typically involves multi-step processes that combine aromatic substitution and esterification reactions. Recent optimizations have focused on improving yield and purity through the use of catalytic systems and green chemistry principles. For example, microwave-assisted synthesis has been employed to accelerate reaction rates while minimizing energy consumption and waste generation.

From an analytical standpoint, ethyl 4-(4-fluorophenyl)-4-oxobutanoate can be characterized using a variety of spectroscopic techniques. High-resolution mass spectrometry (HRMS) provides precise molecular weight determination, while nuclear magnetic resonance (NMR) spectroscopy offers detailed insights into its molecular structure. These analytical tools are essential for confirming the identity and purity of the compound during both synthesis and quality control processes.

In terms of safety and handling, ethyl 4-(fluorophenyl)-butyrate derivatives are generally considered non-hazardous under normal laboratory conditions. However, precautions should be taken to avoid prolonged exposure or inhalation of dust or vapors. Proper ventilation and personal protective equipment (PPE) are recommended when working with this compound to ensure safe handling practices.

Looking ahead, ethyl 4-(fluorophenyl)-butyrate is expected to remain an important molecule in chemical research due to its versatility and bioactivity potential. Ongoing research aims to uncover new synthetic routes, optimize its pharmacokinetic properties, and explore its therapeutic applications further. As our understanding of this compound deepens, it is likely to contribute significantly to advancements in drug discovery and development.

• 1999-00-4(Ethyl 3-(4-Fluorophenyl)-3-Oxopropanoate)
• 63131-29-3(Methyl 4-fluorobenzoylacetate)
• 260246-17-1(methyl 3-(3-fluorophenyl)-3-oxopropanoate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)